ABBV
AbbVie's Stellar Q1 Performance Sets the Stage for a Bright Future
AbbVie has kicked off the year with a resounding success, exceeding expectations across multiple therapeutic areas. The company's first-quarter results have been nothing short of impressive, with adjusted earnings per share (EPS) of $2.46 and total net revenues of over $13.3 billion, a whopping $550 million